project id: TCGA-SKCM; case submitter id: TCGA-FS-A1YX; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.9; rna integrity number: 8.3; age at index: 39; days to birth: -14387; days to death: 1478; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1962; year of death: 2005; age at diagnosis: 14387; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T2; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C49.9; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Connective, subcutaneous and other soft tissues, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2001; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 3485; initial weight: 70.0; oct embedded: false; preservation method: Unknown; sample id: 15d812e2-2bb0-47f0-80d2-5f72697ba71b; sample submitter id: TCGA-FS-A1YX-06A; portion id: 3c3617bd-37ed-4686-995c-f8a0ac10a542; portion submitter id: TCGA-FS-A1YX-06A-11; slide id: f309efc8-d64b-4c8a-8221-ae602992aeac; slide submitter id: TCGA-FS-A1YX-06A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 15.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 20.0; percent tumor cells: 55.0; percent tumor nuclei: 65.0; section location: TOP;